AHA: Niacin Bests Ezetimibe as Add-On Therapy (CME/CE)

ORLANDO (MedPage Today) In high-risk patients on long-term statin therapy, boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis than going for additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.

source : www.medpagetoday.com

Related News:

• SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)

Details :
Submited at Monday, November 16th, 2009 at 1:00 am on Cardiology by Alina
Comment RSS 2.0 - leave a comment - trackback